Michael J. Bonello - Jun 17, 2021 Form 4 Insider Report for PRA Health Sciences, Inc. (PRAH)

Role
EVP & CFO
Signature
By: /s/ Christopher L. Gaenzle, by power of attorney
Stock symbol
PRAH
Transactions as of
Jun 17, 2021
Transactions value $
-$4,271,454
Form type
4
Date filed
6/21/2021, 05:27 PM
Previous filing
Jun 30, 2021
Next filing
Jul 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAH Common Stock Options Exercise $2.91M +35.7K +300.58% $81.61 47.5K Jun 17, 2021 Direct
transaction PRAH Common Stock Options Exercise $800K +8.33K +17.54% $95.94 55.9K Jun 17, 2021 Direct
transaction PRAH Common Stock Options Exercise $884K +8.56K +15.32% $103.30 64.4K Jun 17, 2021 Direct
transaction PRAH Common Stock Sale -$33.3K -200 -0.31% $166.70 64.2K Jun 17, 2021 Direct F1, F2
transaction PRAH Common Stock Sale -$4.1M -24.4K -37.98% $168.17 39.8K Jun 17, 2021 Direct F1, F3
transaction PRAH Common Stock Sale -$3.82M -22.6K -56.71% $169.05 17.2K Jun 17, 2021 Direct F1, F4
transaction PRAH Common Stock Sale -$912K -5.38K -31.18% $169.67 11.9K Jun 17, 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAH Stock Options (Right to Buy) Options Exercise $0 -35.7K -64.07% $0.00 20K Jun 17, 2021 Common Stock 35.7K $81.61 Direct F6
transaction PRAH Stock Options (Right to Buy) Options Exercise $0 -8.33K -33.34% $0.00 16.7K Jun 17, 2021 Common Stock 8.33K $95.94 Direct F7
transaction PRAH Stock Options (Right to Buy) Options Exercise $0 -8.56K -33.33% $0.00 17.1K Jun 17, 2021 Common Stock 8.56K $103.30 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.55 to $166.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.57 to $168.56, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.57 to $169.55, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.57 to $169.83, inclusive.
F6 12,877 options vested on April 26, 2019 and 4,339 options vested on April 26, 2020 upon satisfaction of certain performance criteria.
F7 The option vests in three equal annual installments of 8,334 beginning on August 13, 2020.
F8 The option vests in three equal annual installments of 8,556 beginning on June 1, 2021.